Largest biotech by net assets

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

Gilead Sciences leads the 24 biotech ranked by net assets, at NOK 220.2B, ahead of BioNTech (NOK 206.8B) and Biogen (NOK 177B). Figures as of 18 Nov 2026, 14:31 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
First
Gilead SciencesNOK 220.2B
Median
NOK 19.5B
Combined market value
NOK 8.15T
Countries
5

Market values as of .

Largest biotech by net assets
#CompanyNet assets ↓Market capPriceToday1 yearPrice, 30 daysCountry
1Gilead SciencesGILD · Health CareNOK 220.2BNOK 2.02TNOK 1,627.54 1.43% down 33% up United States
2BioNTechBNTX · Health CareNOK 206.8BNOK 202.7BNOK 817.70 0.64% down 16% down Germany
3BiogenBIIB · Health CareNOK 177BNOK 354.1BNOK 2,395.29 1.51% down 49% up United States
4AmgenAMGN · Health CareNOK 84BNOK 2.37TNOK 4,376.60 1.45% down 34% up United States
5ModernaMRNA · Health CareNOK 83.9BNOK 804.3BNOK 1,987.90 0.88% down 755% up United States
6argenxARGX · Health CareNOK 71BNOK 577.7BNOK 9,186.78 0.02% down 4% up Belgium
7QiagenQGEN · Health CareNOK 36.6BNOK 99.6BNOK 482.11 0.07% down 12% up Netherlands
8Neurocrine BiosciencesNBIX · Health CareNOK 31.5BNOK 162BNOK 1,600.10 0.55% down 20% up United States
9VaxcytePCVX · Health CareNOK 26BNOK 91BNOK 574.87 0.20% down 22% up United States
10ExelixisEXEL · Health CareNOK 21BNOK 161.6BNOK 662.15 0.32% down 63% up United States
11Bio-TechneTECH · Health CareNOK 20.4BNOK 110.8BNOK 705.21 0.12% up 26% up United States
12RepligenRGEN · Health CareNOK 20.4BNOK 103.5BNOK 1,619.49 2.97% up 5% up United States
13CRISPR TherapeuticsCRSP · Health CareNOK 18.6BNOK 38.1BNOK 392.51 0.81% up 21% down Switzerland
14Revolution MedicinesRVMD · Health CareNOK 15.8BNOK 339.8BNOK 1,571.15 0.41% down 131% up United States
15Kymera TherapeuticsKYMR · Health CareNOK 15.3BNOK 99.8BNOK 1,168.65 0.83% down 87% up United States
16Krystal BiotechKRYS · Health CareNOK 11.8BNOK 85.5BNOK 2,885.99 0.32% down 46% up United States
17ImmunovantIMVT · Health CareNOK 8.3BNOK 67BNOK 323.70 0.51% up 43% up United States
18CG OncologyCGON · Health CareNOK 7.3BNOK 69.3BNOK 775.80 1.34% up 85% up United States
19Twist BioscienceTWST · Health CareNOK 4.6BNOK 73.1BNOK 1,072.36 1.27% down 340% up United States
20Scholar Rock HoldingSRRK · Health CareNOK 2.4BNOK 52.4BNOK 429.41 1.77% down 14% up United States
21Adaptive BiotechnologiesADPT · Health CareNOK 2.1BNOK 44.8BNOK 276.67 0.14% up 88% up United States
22Kodiak SciencesKOD · Health CareNOK 1.5BNOK 61.2BNOK 935.91 0.30% down 396% up United States
23Halozyme TherapeuticsHALO · Health CareNOK 473.4MNOK 105.6BNOK 925.97 0.51% down 37% up United States
24ImmunityBioIBRX · Health Care-NOK 4.9BNOK 64.2BNOK 60.32 0.64% down 193% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 9.6975 NOK).

Questions and answers

Which biotech rank first by net assets?

Gilead Sciences (NOK 220.2B), BioNTech (NOK 206.8B) and Biogen (NOK 177B) are the top three of the 24 biotech ranked by net assets as of 18 Nov 2026, 14:31 UTC.

How many biotech are in this ranking?

24 are ranked by net assets.

What are these biotech worth together?

The 24 biotech ranked by net assets have a combined market value of NOK 8.15T as of 18 Nov 2026, 14:31 UTC.

What does ranking by net assets measure?

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

Cite this page

Funkfolio, “Largest biotech by net assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=net-assets

Underlying data: Yahoo Finance; SEC EDGAR.